Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-84.11M
↓ 82% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-46.21M
Historical baseline
PeriodValueYoY Change
2025$-84.11M-5.7%
2024$-79.55M-32.9%
2023$-59.85M-85.3%
2022$-32.29M-100.0%
2021$-16.15M-205.1%
2020$-5.29M-